DK0783307T3 - Anvendelse af 2,4-diaminopyrimidin-3-oxid eller et salt deraf til behandling af forstyrrelser i modning og strukturering af kollagen - Google Patents

Anvendelse af 2,4-diaminopyrimidin-3-oxid eller et salt deraf til behandling af forstyrrelser i modning og strukturering af kollagen

Info

Publication number
DK0783307T3
DK0783307T3 DK95931260T DK95931260T DK0783307T3 DK 0783307 T3 DK0783307 T3 DK 0783307T3 DK 95931260 T DK95931260 T DK 95931260T DK 95931260 T DK95931260 T DK 95931260T DK 0783307 T3 DK0783307 T3 DK 0783307T3
Authority
DK
Denmark
Prior art keywords
pct
structuring
disorders
oxide
maturation
Prior art date
Application number
DK95931260T
Other languages
English (en)
Inventor
Yann Mahe
Lionel Breton
Jean-Baptiste Galey
Bruno Bernard
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of DK0783307T3 publication Critical patent/DK0783307T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK95931260T 1994-09-19 1995-09-19 Anvendelse af 2,4-diaminopyrimidin-3-oxid eller et salt deraf til behandling af forstyrrelser i modning og strukturering af kollagen DK0783307T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9411133A FR2724561B1 (fr) 1994-09-19 1994-09-19 Utilisation du 2,4-diamino pyrimidine 3-oxyde ou de l'un de ses sels dans le traitement des desordres de la maturation et de la structuration du collagene
PCT/FR1995/001197 WO1996009048A1 (fr) 1994-09-19 1995-09-19 Utilisation du 2,4-diamino pyrimidine 3-oxyde ou de l'un de ses sels dans le traitement des desordres de la maturation et de la structuration du collagene

Publications (1)

Publication Number Publication Date
DK0783307T3 true DK0783307T3 (da) 2002-06-03

Family

ID=9467049

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95931260T DK0783307T3 (da) 1994-09-19 1995-09-19 Anvendelse af 2,4-diaminopyrimidin-3-oxid eller et salt deraf til behandling af forstyrrelser i modning og strukturering af kollagen

Country Status (22)

Country Link
US (1) US5846552A (da)
EP (1) EP0783307B1 (da)
JP (1) JP2945482B2 (da)
KR (1) KR100250939B1 (da)
CN (1) CN1070702C (da)
AT (1) ATE213414T1 (da)
AU (1) AU691336B2 (da)
BR (1) BR9508841A (da)
CA (1) CA2199995C (da)
CZ (1) CZ284476B6 (da)
DE (1) DE69525539T2 (da)
DK (1) DK0783307T3 (da)
ES (1) ES2171550T3 (da)
FI (1) FI971127L (da)
FR (1) FR2724561B1 (da)
HU (1) HU223143B1 (da)
MX (1) MX9701996A (da)
NO (1) NO311784B1 (da)
PL (1) PL186385B1 (da)
PT (1) PT783307E (da)
RU (1) RU2153874C2 (da)
WO (1) WO1996009048A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69831186T2 (de) * 1997-04-30 2006-06-08 Jsr Corp. Orientierungsschicht für Flüssigkristall und Verfahren zu ihrer Herstellung
US7763587B2 (en) 2002-06-13 2010-07-27 L'oreal S.A. Derivative of glucose and of vitamin F, compositions comprising it, uses and preparation process
US7326717B2 (en) 2003-05-06 2008-02-05 L'oreal Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof
FR2871688B1 (fr) 2004-06-16 2008-05-16 Oreal Procede pour favoriser la penetration d'un actif et composition permettant sa mise en oeuvre
US7300649B2 (en) 2005-02-11 2007-11-27 Genepharm, Inc. Cosmetic and cosmeceutical compositions for restoration of skin barrier function
FR2902324B1 (fr) * 2006-06-20 2009-04-03 Oreal Utilisation d'acide ellagique pour le traitement de la canitie
EP1897533A1 (en) * 2006-09-08 2008-03-12 Revotar Biopharmaceuticals AG Use of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-alpha -D-mannopyranosyl-oxy)-phenyl] hexane for the preparation of cosmetic compositions
EP1946756A1 (en) * 2007-01-17 2008-07-23 Revotar Biopharmaceuticals AG Use of entacapone in cosmetic, dermatological and pharmaceutical compositions
CN102131495B (zh) 2008-07-29 2017-07-04 欧莱雅 微生物用于治疗头皮病症的美容应用
FR2951938B1 (fr) 2009-10-30 2012-01-06 Oreal Utilisation d'un extrait de punica granatum pour lutter contre la canitie
CN104398418A (zh) * 2014-11-06 2015-03-11 陈爱华 一种防脱发护发素
FR3130153A1 (fr) 2021-12-15 2023-06-16 L'oreal Utilisation d’au moins un dérivé de pyrimidine 3-oxyde pour renforcer la fonction barrière de la peau
FR3149509A1 (fr) 2023-06-08 2024-12-13 L'oreal Procédé utilisant la radiofréquence et une composition cosmétique
FR3150431A1 (fr) * 2023-06-30 2025-01-03 L'oreal Utilisation d’au moins un dérivé de pyrimidine 3-oxyde pour prévenir et/ou traiter les signes cutanés du vieillissement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0049902A3 (en) * 1980-10-15 1982-09-01 Teijin Limited Novel thiazolo(3,2-a)pyrimidines, derivatives thereof, processes for production thereof, and pharmaceutical use thereof
FR2644460A1 (fr) * 1989-03-16 1990-09-21 Oreal Esters retinoiques de d-desosamine, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
LU87766A1 (fr) * 1990-07-20 1992-03-11 Oreal Utilisation de derives de pyrimidine 3-oxyde pour freiner la chute des cheveux et compositions topiques mises en oeuvre
EP0548883A1 (de) * 1991-12-24 1993-06-30 Hoechst Aktiengesellschaft Substituierte Pyridin-N-oxide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
AU691336B2 (en) 1998-05-14
BR9508841A (pt) 1999-05-04
JPH10506886A (ja) 1998-07-07
PT783307E (pt) 2002-07-31
NO971182L (no) 1997-05-14
CN1070702C (zh) 2001-09-12
EP0783307B1 (fr) 2002-02-20
DE69525539T2 (de) 2002-09-26
ATE213414T1 (de) 2002-03-15
US5846552A (en) 1998-12-08
FI971127A0 (fi) 1997-03-18
PL319279A1 (en) 1997-08-04
CZ284476B6 (cs) 1998-12-16
ES2171550T3 (es) 2002-09-16
FR2724561A1 (fr) 1996-03-22
KR970705998A (ko) 1997-11-03
FI971127A7 (fi) 1997-03-18
FR2724561B1 (fr) 1996-12-13
CZ84297A3 (en) 1997-08-13
KR100250939B1 (ko) 2000-05-01
CN1159755A (zh) 1997-09-17
CA2199995C (fr) 2002-01-15
CA2199995A1 (fr) 1996-03-28
HU223143B1 (hu) 2004-03-29
PL186385B1 (pl) 2004-01-30
NO971182D0 (no) 1997-03-14
RU2153874C2 (ru) 2000-08-10
DE69525539D1 (de) 2002-03-28
MX9701996A (es) 1997-06-28
FI971127L (fi) 1997-03-18
HUT76796A (en) 1997-11-28
EP0783307A1 (fr) 1997-07-16
JP2945482B2 (ja) 1999-09-06
WO1996009048A1 (fr) 1996-03-28
AU3476595A (en) 1996-04-09
NO311784B1 (no) 2002-01-28

Similar Documents

Publication Publication Date Title
DK0783307T3 (da) Anvendelse af 2,4-diaminopyrimidin-3-oxid eller et salt deraf til behandling af forstyrrelser i modning og strukturering af kollagen
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
ES2136624T3 (es) Implante biocompatible para regular la ovulacion en yeguas.
SE9404196D0 (sv) New antithrombotic formulation
DE69532804D1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
FR2731907B1 (fr) Composition dermatologique et/ou cosmetique depigmentante et utilisation dans une methode cosmetique
DE69800859D1 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
DE69917756D1 (de) Methoden zur behandlung von neurombedingten schmerzen
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
ATE211650T1 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
DE69421705D1 (de) Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
ATE221528T1 (de) Neue 1,4-dihydropyridinderivate und deren therapeutische anwendung
SE9403861D0 (sv) Novel medicinal use
ATE399551T1 (de) Hilfsmittel und methoden zur transdermalen applikation von felodipin
DE3776662D1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
DK0674508T3 (da) 4-guanidinobutyramid til forbedring af blodcirkulation
UA26407C2 (uk) Спосіб очищеhhя уражеhих шкірhих покривів людиhи при захворюваhhі псоріазом